key: cord-0887781-juvrora3
authors: Wijeysundera, D. N.; Khadaroo, R. G.
title: Surgery after a previous SARS‐CoV‐2 infection: data, answers and questions
date: 2021-04-17
journal: Anaesthesia
DOI: 10.1111/anae.15490
sha: 5e8ccf0821951926d78096e901ff56c6f73dbf48
doc_id: 887781
cord_uid: juvrora3

nan

of the SARS-CoV-2 corona virus has been profound. By

March 2021, more than 121 million people worldwide had been infected, of whom 2.7 million had died [1] . In a typical year, more than 300 million surgical procedures are performed worldwide [2] . It is, therefore, unsurprising that the COVID-19 pandemic has significantly impacted on the safe and timely delivery of surgical care. For example, more than 28 million surgical procedures were delayed or cancelled during the first wave of the pandemic alone [3] . For example, a patient with a drug-eluting coronary stent experiences elevated risk when surgery is performed sooner than 6 months after stent insertion [4] , while a patient with a prior venous thromboembolism experiences the greatest risk from temporary withholding of anticoagulation when surgery is performed within the first month of a thromboembolic episode [5] . It is recognised that surgery during active SARS-CoV-2 infection is associated with increased risks of death and pulmonary complications [6, 7] ; hence, it should be deferred whenever possible. Yet once the active infection has resolved and the patient is no longer infectious, when might elective (or 'scheduled') surgery safely proceed? Relevant data are limited. The COVIDSurg collaboration reported the outcomes of 122 patients who had elective cancer surgery following previous SARS-CoV-2 infection (defined by positive nasopharyngeal swab test) and had no evidence of active infection at the time of surgery [6] . In this relatively small cohort, the unadjusted risks of death and pulmonary complications were elevated when surgery proceeded during the period from 7 to 28 days following a positive SARS-CoV-2 swab. These findings mirror those of a French multicentre cohort study [7] , where 147 patients who had surgery within 5 to 30 days of a positive SARS-CoV-2 nasopharyngeal swab test asymptomatic infections. What were the key findings?

Patients with prior SARS-CoV-2 infection experienced higher risks of 30-day mortality and pulmonary complications than uninfected patients until 7 or more weeks had elapsed from the initial diagnosis of infection.

Elevated risk persisted in sub-groups defined by procedure complexity (major vs. minor surgery) and urgency (elective vs. emergency surgery) (Fig. 1a) research in the peri-operative setting is possible, this is to be commended and must be continued.

World Health Organization. WHO Coronavirus Disease (COVID-19) Dashboard

Estimate of the global volume of surgery in 2012: an assessment supporting improved health outcomes

Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans

Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study

Management of anticoagulation before and after elective surgery

Delaying surgery for patients with a previous SARS-CoV-2 infection

Risks of early mortality and pulmonary complications following surgery in patients with COVID-19

ASA and APSF joint statement on elective surgery and anesthesia for patients after COVID-19 infection

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

Mortality after surgery in Europe: a 7 day cohort study

Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries

Perioperative patient outcomes in the African Surgical Outcomes Study: a 7-day prospective observational cohort study

Prediction of postoperative pulmonary complications in a population-based surgical cohort

Proportion of asymptomatic infection among COVID-19 positive persons and their transmission potential: a systematic review and metaanalysis

Extrapulmonary manifestations of COVID-19

Perioperative morbidity and mortality of patients with COVID-19 who undergo urgent and emergent surgical procedures

Factors associated with surgical mortality and complications among patients with and without Coronavirus Disease 2019 (COVID-19) in Italy

A randomized trial comparing antibiotics with appendectomy for appendicitis

SARS-CoV-2 infection, COVID-19 and timing of elective surgery: a multidisciplinary consensus statement on behalf of the Association of Anaesthetists, the Centre for Peri-operative Care, the Federation of Surgical Specialty Associations, the Royal College of Anaesthetists and the

Surgical trainee research collaboratives in the UK: an observational study of research activity and publication productivity